NRXP — NRX Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $107.81m
- $81.53m
- $1.23m
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: NRx Pharmaceuticals Announces Plan To Distribute Shares Of Hope Therapeutics And Royalty Rights On Ketamine Sales To Existing NRx Shareholders
Brief: Nrx Pharmaceuticals Inc says Announced A Proposal To Simultaneously Change Cusip Under Which Company's Shares Are Traded
Brief: Nrx Pharmaceuticals Inc says Company To Receive First Allocation Of Ketamine For Sale By Month End
Brief: NRx Pharmaceuticals Announces Last Patient, Last Visit In Its Phase 2b/3 Trial Of NRX-101 In Suicidal Treatment Resistant Bipolar Depression
Brief: NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share
Brief: NRX Pharmaceuticals Announces Pricing Of $1.5 Million Underwritten Public Offering Of Common Stock
Brief: Nrx Pharmaceuticals Announces Advance Of $5 Million Milestone Payment From Partners
Brief: NRX Pharmaceuticals Announces Enrollment Completion Of Its Phase 2B/3 Trial Of Nrx-101 In Suicidal Treatment Resistant Bipolar Depression
Brief: NRx Pharmaceuticals Announces Receipt Of Positive Nasdaq Listing Determination
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers
U.S. STOCKS ON THE MOVE-Halozyme, Scorpio Tankers, Advanced Micro Devices
U.S. STOCKS ON THE MOVE-InMode, Carrols Restaurant, Tesla
U.S. STOCKS ON THE MOVE-Western Digital, NRx Pharma
NRx Pharma climbs on FDA 'fast track' tag for urinary infection treatment
Brief: NRx Pharmaceuticals Says Co To Present Full Compliance Plan To Nasdaq on January 4, 2024